[1]OLIVER AL.Lung cancer:epidemiology and screening［J］．Surg Clin North Am，2022，102(3):335-344．
[2]LEE E，KAZEROONI EA．Lung cancer screening［J］．Semin Respir Crit Care Med，2022，43(6):839-850．
[3]SONG J，YAN Y，CHEN C，et al．Tumor mutational burden and efficacy of chemotherapy in lung cancer［J］．Clin Transl Oncol，2023，25(1):173-184．
[4]YAO S，FAN LY，LAM EW．The FOXO3-FOXM1 axis:A key cancer drug target and a modulator of cancer drug resistance［J］．Semin Cancer Biol，2018，50(2):77-89．
[5]CUI W，XIE N，LAM EW，et al．High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients:A study from Swedish clinical trial of preoperative radiotherapy to big database analysis［J］．Heliyon，2023，9(5):e15342-e15356．
[6]LIU H，SONG Y，QIU H，et al．Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis［J］．Cell Death Differ，2020，27(3):966-983．
[7]ZHANG Y，GE P，ZHOU D，et al．Circular RNA FOXO3 accelerates glycolysis and improves cisplatin sensitivity in lung cancer cells via the miR-543/Foxo3 axis［J］．Oncol Lett，2021，22(6):839-848．
[8]王红，冯帅，史磊，等．菊苣酸的研究进展［J］．药学研究，2021，40(9):614-619．
WANG H，FENG S，SHI L，et al．Research progress of cichoric acid［J］．Journal of Pharmaceutical Research，2021，40(9):614-619．
[9]SUN X，ZHANG X，ZHAI H，et al．Chicoric acid (CA) induces autophagy in gastric cancer through promoting endoplasmic reticulum (ER) stress regulated by AMPK［J］．Biomed Pharmacother，2019，118(1):109144-109153．
[10]陈金锐，李红，于音．菊苣酸通过磷脂酰肌醇3-激酶/蛋白激酶B信号通路抑制口腔癌KB细胞增殖,侵袭与黏附的研究［J］．中国临床药理学杂志，2022，38(11):1199-1202．
CHEN JR，LI H，YU Y．Chicory acid inhibits the proliferation,invasion and adhesion of oral carcinoma KB cells through the phosphatidylinositol 3 kinase/protein kinase B signaling pathway［J］．The Chinese Journal of Clinical Pharmacology，2022，38(11):1199-1202．
[11] 周锋，冯媛，王二愿，等．miR-20a调控P-gp对非小细胞肺癌细胞A549顺铂化疗敏感性的影响［J］．解剖科学进展，2022，28(5):560-563，572．
ZHOU F，FENG Y，WANG EY，et al．Effect of miR-20a-regulated P-gp on cisplatin chemosensitivity of non-small cell lung cancer cell line A549［J］．Progress of Anatomical Sciences，2022，28(5):560-563，572．
[12]PEI Q，LUO Y，CHEN Y，et al．Artificial intelligence in clinical applications for lung cancer:diagnosis,treatment and prognosis［J］．Clin Chem Lab Med，2022，60(12):1974-1983．
[13]KOMICI K，BENCIVENGA L，NAVANI N，et al．Frailty in patients with lung cancer:a systematic review and meta-analysis［J］．Chest，2022，162(2):485-497．
[14]KONOSHENKO M，LANSUKHAY Y，KRASILNIKOV S，et al．MicroRNAs as predictors of lung-cancer resistance and sensitivity to cisplatin［J］．Int J Mol Sci，2022，23(14):7594-7615．
[15]JIAO J，PAN M，LIU X，et al．An ultrasensitive non-enzymatic sensor for quantitation of anti-cancer substance chicoric acid based on bimetallic nanoalloy with polyetherimide-capped reduced graphene oxide［J］．Nanomaterials (Basel)，2020，10(3):499-511．
[16]MOUNA R，BROISAT A，AHMED A，et al．Antiproliferative activity,cell-cycle arrest,apoptotic induction and LC-HRMS/MS analyses of extracts from two Linum species［J］．Pharm Biol，2022，60(1):1491-1501．
[17]MOORE XTR，GHEGHIANI L，FU Z．The role of polo-like kinase 1 in regulating the forkhead box family transcription factors［J］．Cells，2023，12(9):1344-1366．
[18]GHOSH S，SINGH R，VANWINKLE ZM，et al．Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis［J］．Theranostics，2022，12(12):5574-5595．
[19]CAO Y，LI P，WANG H，et al．SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis［J］．Cancer Med，2021，10(4):1394-1404．
[20]GUAN S，CHEN X，CHEN Y，et al．FOXM1 variant contributes to gefitinib resistance via activating Wnt/β-Catenin signal pathway in patients with non-small cell lung cancer［J］．Clin Cancer Res，2022，28(17):3770-3784．